PRR - Commercialisation in Dubai

ASX/Media Release
31th May 2011

CVACTM GRANTED APPROVAL IN DUBAI HEALTHCARE CITY; PRIMA
COMMENCES COMMERCIALIZATION PLANS IN MIDDLE EAST

• First commercial sales of CVac anticipated in 2011

• First approval globally to make CVac commercially available

• Dr Hind Al Saadi appointed General Manager of Prima BioMed Middle East

• Prima to partner with the world-class City Hospital, the first hospital
established in Dubai Healthcare City

• Dubai Healthcare City is the premier hub for medical innovation and patient
care in the Middle East

• Significant opportunity for Prima to tap into US$517 million Middle East
cancer therapy market.

Shares under $2.5 million market cap

 

PRR

http://www.primabiomed.com.au/investor/analyst_reports_pdf/100511_National_Securities_Research_Report.pdf

Silver Graph

CEO rise

CEO rise (as predicted)..

in excess of 100% rise in the spare price, if you sold at peak.

Don't get left holding at the top..